Trial Profile
The Effect of telaprevir-based triple therapy for chronic hepatitis C patients on gastric emptying
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 May 2014
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Pharmacodynamics
- 12 May 2014 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 25 Nov 2013 New trial record